Create separate drug controller for AYUSH medicines: Parliamentary Committee Ruby Khatun Khatun8 April 2018 10:30 AM ISTNew Delhi: A parliamentary committee sought the creation of a separate drug controller for AYUSH medicines and drugs in a time-bound manner to ensure...
Parkway Pantai appoints Dr Ajay Bakshi as CEO of India operations Ruby Khatun Khatun8 April 2018 10:00 AM ISTNew Delhi: Parkway Pantai, one of Asia’s largest private healthcare service providers, has appointed Dr Ajay Bakshi as the Chief Executive Officer –...
Boehringer Ingelheim partners with OSE Immunotherapeutics to develop pioneering checkpoint inhibitor for advanced solid tumors Ruby Khatun Khatun8 April 2018 9:45 AM ISTBoehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, announced a...
Novo Nordisk buys blood drug licence to boost anaemic biopharma business Ruby Khatun Khatun8 April 2018 9:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk has secured the global license for U.S. biotech company EpiDestiny’s sickle cell disease (SCD) program in a...
Health ministry bans sale of 14 steroid creams sans doctor’s prescription Ruby Khatun Khatun7 April 2018 2:10 PM ISTNew Delhi: Through a recent gazette notification, Ministry of Health And Family Welfare has banned the over-the-counter (OTC) sale of 14 steroid-based...
Lupin gets EIR from USFDA for Pithampur facility Ruby Khatun Khatun7 April 2018 10:30 AM ISTNew Delhi: Drug firm Lupin said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1...
MTaI suggests gradual rollout of public procurement guidelines Ruby Khatun Khatun7 April 2018 10:00 AM ISTNew Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
Natco launches generic version of multiple sclerosis drug in India Ruby Khatun Khatun7 April 2018 10:00 AM ISTNew Delhi: Drug firm Natco Pharma said it has launched a generic version of Teriflunomide tablets used for the treatment of relapsing and remitting...
AbbVie, Samsung Bioepis in deal, Humira biosimilar US release in 2023 Ruby Khatun Khatun7 April 2018 9:30 AM ISTAbbVie Inc said it signed a deal with Samsung Bioepis and its joint venture partner Biogen Inc that would fend off U.S. competition of their...
Johnson and Johnson loses trial over claims linking cancer to asbestos in talc Ruby Khatun Khatun7 April 2018 9:30 AM ISTJohnson and Johnson suffered its first trial loss in a lawsuit claiming its talc-based products including Johnson’s Baby Powder contain cancer-causing...
Delhi HC asks Fortis to respond to Daiichi's plea on hospital assets Ruby Khatun Khatun6 April 2018 11:10 AM ISTNew Delhi: The Delhi High Court asked Fortis Healthcare Ltd, which is going through the process of restructuring, to give its response on Japanese...
Chemists in Ahmedabad to call shutter down before 11pm Ruby Khatun Khatun6 April 2018 10:43 AM ISTAHMEDABAD: Most of the chemists across Ahmedabad have taken a collective call to shut shop before 11 pm in order to make time for their families and...
